---
title: "BioKangtai released its performance for the first three quarters, with a net profit attributable to the parent company of 49.1577 million yuan, a decrease of 86%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262856856.md"
description: "BioKangtai released its third-quarter report for 2025, with operating revenue for the first three quarters amounting to 2.063 billion yuan, a year-on-year increase of 2.24%. The net profit attributable to the parent company was 49.1577 million yuan, a year-on-year decrease of 86%. The net profit after deducting non-recurring gains and losses was 27.8789 million yuan, a year-on-year decrease of 90.82%. The basic earnings per share were 0.04 yuan"
datetime: "2025-10-27T09:38:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262856856.md)
  - [en](https://longbridge.com/en/news/262856856.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262856856.md)
generator: "portal-rs"
---

# BioKangtai released its performance for the first three quarters, with a net profit attributable to the parent company of 49.1577 million yuan, a decrease of 86%

According to the Zhitong Finance APP, BioKangtai (300601.SZ) released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 2.063 billion yuan, a year-on-year increase of 2.24%. The net profit attributable to shareholders of the listed company was 49.1577 million yuan, a year-on-year decrease of 86.00%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 27.8789 million yuan, a year-on-year decrease of 90.82%. The basic earnings per share were 0.04 yuan

### Related Stocks

- [300601.CN](https://longbridge.com/en/quote/300601.CN.md)

## Related News & Research

- [11:00 ETCizzle Bio Highlights CIZ1B Biomarker Blood Test for Lung Cancer at Next Generation Dx Summit](https://longbridge.com/en/news/297064751.md)
- [Gama Aviation urges UK HEMS, police operators to start ESN aircraft upgrade planning ahead of 2028 deadline](https://longbridge.com/en/news/297064854.md)
- [Bioretec hosts media event highlighting 500,000 Activa bioresorbable orthopedic implants sold worldwide](https://longbridge.com/en/news/297047388.md)
- [Avcon, Butler National unit, delivers first King Air B200 mosquito-control aircraft modification](https://longbridge.com/en/news/297039183.md)
- [Appeals court declines to toss McIver case as panel splits on selective prosecution claims](https://longbridge.com/en/news/297070472.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**